SHANGHAI, Aug 27 (Reuters) – Chinese technology conglomerate Huawei plans to expand its AI cooperation with local pharmaceutical firms into drug development and clinical practice, a senior executive
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Lowe's late single lifts Guardians past Rays 7-3 in ALCS opener
VIDEO SHOWS: HIGHLIGHTS OF GAME ONE OF THE MLB AMERICAN LEAGUE CHAMPIONSHIP SERIES BETWEEN THE…
Tennis-Swiatek aiming to end year on a positive note as WTA Finals spot hangs in balance
Oct 13 (Reuters) - Iga Swiatek is on the brink of missing the WTA Finals…
AI investment props up global growth, but war and debt threaten outlook, IMF says
By David Lawder BANGKOK, Oct 13 (Reuters) - The global economy will still manage to…
